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Abstract 104 
Study question: Do women who have diabetes before menopause have their 105 
menopause at an earlier age compared to women without diabetes? 106 
 107 
Summary answer: Although overall there was no association between diabetes and 108 
age at menopause, our study suggests that early-onset diabetes may accelerate 109 
menopause. 110 
 111 
What is known already: Today, more women of childbearing age are being 112 
diagnosed with diabetes, but little is known about the impact of diabetes on 113 
reproductive health.  114 
 115 
Study design, size, duration: We investigated the impact of diabetes on age at 116 
natural menopause (ANM) in 258,898 women from the European Prospective 117 
Investigation into Cancer and Nutrition (EPIC), enrolled between 1992 and 2000.  118 
 119 
Participants/materials, setting, methods: Determinant and outcome information 120 
was obtained through questionnaires. Time-dependent Cox regression analyses 121 
were used to estimate the associations of diabetes and age at diabetes diagnosis 122 
with ANM, stratified by center and adjusted for age, smoking, reproductive and 123 
diabetes risk factors and with age from birth to menopause or censoring as the 124 
underlying time scale. 125 
 126 
Main results and the role of chance:  127 
Overall, no association between diabetes and ANM was found (hazard ratio (HR) = 128 
0.94; 95% confidence interval (CI) 0.89-1.01). However, women with diabetes before 129 
the age of 20 years had an earlier menopause (10-20 years: HR = 1.43; 95% CI 1.02-130 
2.01, < 10 years: HR = 1.59; 95% CI 1.03-2.43) compared to non-diabetic women, 131 
whereas women with diabetes at age 50 years and older had a later menopause (HR 132 
= 0.81; 95% CI 0.70-0.95). None of the other age groups were associated with ANM.  133 
 134 
Limitations, reasons for caution: Strengths of the study include the large sample 135 
size and the broad set of potential confounders measured. However, results may 136 
have been underestimated due to survival bias. We cannot be sure about the 137 
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sequence of the events in women with a late age at diabetes, as both events then 138 
occur in a short period. We could not distinguish between type1 and type 2 diabetes. 139 
 140 
Wider implications of the findings: Based on the literature, an accelerating effect 141 
of early-onset diabetes on ANM might be plausible. A delaying effect of late-onset 142 
diabetes on ANM has not been reported before, and is not in agreement with recent 143 
studies suggesting the opposite association.  144 
 145 
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Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research 157 
Fund (WCRF), Statistics Netherlands (The Netherlands); ERC-2009-AdG 232997 158 
and Nordforsk, Nordic Centre of Excellence programme on Food, Nutrition and 159 
Health. (Norway); Health Research Fund (FIS), Regional Governments of Andalucía, 160 
Asturias, Basque Country, Murcia (no. 6236) and Navarra, ISCIII RETIC 161 
(RD06/0020) (Spain); Swedish Cancer Society, Swedish Scientific Council and 162 
Regional Government of Skåne and Västerbotten (Sweden); Cancer Research UK, 163 
Medical Research Council, Stroke Association, British Heart Foundation, Department 164 
of Health, Food Standards Agency, and Wellcome Trust (UK). None of the authors 165 
reported a conflict of interest.  166 
 167 
 168 
Keywords: Age at natural menopause, diabetes, time-dependent modeling, cox 169 
proportional hazards analyses  170 
9 
 
 
Introduction 171 
Menopause is a universal event in women’s reproductive life, but the timing of onset 172 
varies widely. In the Western world, age at natural menopause (ANM) typically 173 
ranges between 40 and 60 years, with an average age of onset of 51 years (te Velde 174 
and Pearson, 2002). Although the exact underlying mechanisms are not completely 175 
understood, timing of menopause is considered to be a complex trait, being 176 
influenced by both genetic and environmental factors. Smoking is the best-177 
established environmental factor affecting ANM, with menopause occurring 1-2 years 178 
earlier in smokers (Gold, 2011). Other factors that have been linked to an earlier 179 
menopause are nulliparity and low socioeconomic status, while use of oral 180 
contraceptives (OCs) tends to delay menopause (Gold, 2011). Several studies have 181 
investigated the association of physical activity and dietary factors with ANM, but 182 
their impact seems to be small and not always consistent (Gold, 2011).  183 
Next to genetic and environmental factors, chronic metabolic diseases may also 184 
influence ANM. There is some evidence suggesting that diabetes may accelerate 185 
menopausal onset. Women with type 1 diabetes (T1D) have an earlier decline of 186 
inhibin B and anti-Müllerian hormone (AMH) levels, which is indicative of premature 187 
ovarian ageing (Soto, et al., 2009). Furthermore, women with T1D have been 188 
reported to enter menopause 5 years earlier than non-diabetic women (Dorman, et 189 
al., 2001), although a later study did not confirm this (Sjoberg, et al., 2011). In 190 
addition, we have previously shown that women with an adverse metabolic risk factor 191 
profile enter menopause earlier (Kok, et al., 2006), and recently a smaller ovarian 192 
reserve has been observed in premenopausal women with type 2 diabetes (T2D) 193 
(Isik, et al., 2012).  194 
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Given the increasing prevalence of diabetes in women of childbearing age 195 
(Lawrence, et al., 2008, Patterson, et al., 2009), more women could be exposed to 196 
potential adverse effects of diabetes on reproductive health. In the present study, we 197 
therefore examined the impact of diabetes on ANM in a large European cohort.  198 
 199 
Materials and Methods 200 
Study population 201 
The European Prospective Investigation into Cancer and Nutrition (EPIC) study is a 202 
multicenter prospective cohort study aimed at investigating the relations between 203 
diet, lifestyle, and genetic factors and the incidence of cancer and other chronic 204 
diseases. The cohort was initiated in the early 1990s in 23 centers from 10 European 205 
countries (France, Italy, Spain, UK, Netherlands, Greece, Germany, Sweden, 206 
Denmark and Norway). Details of EPIC, in particular on design, study population and 207 
procedures for baseline data collection have been described previously (Riboli, 1992, 208 
Riboli and Kaaks, 1997). In brief, 519,978 men and women, mostly aged 27 to 70 209 
years, were mainly recruited from the general population between 1992 and 2000. 210 
Exceptions were the Oxford cohort, UK (vegetarian volunteers and healthy eaters); 211 
the Utrecht cohort, the Netherlands and the Florence, Italy, cohort (women attending 212 
breast cancer screening); the French cohort (female members of the health 213 
insurance for state school employees); and components of the Italian and Spanish 214 
cohorts (members of local blood donor associations). Baseline questionnaires 215 
included questions on diet, lifestyle, reproductive and medical factors. All participants 216 
provided written informed consent and the study was approved by the local ethics 217 
committees of the participating centers and the Internal Review Board of the 218 
International Agency for Research on Cancer.  219 
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Follow-up differed largely by country, but participants were regularly followed for the 220 
occurrence of various diseases. However, for the current analyses we only use the 221 
baseline data from EPIC.  222 
In total, 367,331 women participated in the EPIC study. For the present study, we 223 
excluded women from the Norwegian cohorts (N = 37,200) and the Swedish cohorts 224 
(N = 30,329), because of lack of data on hysterectomy and/or oophorectomy status. 225 
We further excluded women with missing data on diabetes status (N = 5,891) and 226 
postmenopausal women with missing data on menopausal age (N = 35,013), leaving 227 
258,898 women for the analyses. 228 
 229 
Exposure assessment 230 
Diabetes status, defined as being diagnosed with diabetes, at baseline was based on 231 
self-report and obtained through a questionnaire in which participants were asked if 232 
they had ever been diagnosed with diabetes and if so at what age. In the 233 
questionnaire, no distinction was made between T1D and T2D. In part of the cohort 234 
self-reported diabetes was medically verified (Sluik, et al., 2011): 119,613 women 235 
from 13 centers in five EPIC countries (Italy: Florence, Milan, Naples, Ragusa, Turin; 236 
Spain: Pamplona, San Sebastian; Netherlands: Bilthoven, Utrecht; Germany: 237 
Heidelberg, Potsdam; Denmark; Aarhus, Copenhagen). Of the 2708 self-reports in 238 
these centers, 2030 were confirmed to have diabetes (75%).   239 
 240 
Assessment of menopausal status and age at menopause 241 
The analyses in this paper are based on menstrual status at baseline and 242 
retrospective recall of age at menopause. Menopausal status was defined according 243 
to information on menstruation status and age at enrollment. Women were 244 
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considered as postmenopausal if they reported not having had any menses over the 245 
past 12 months. Women were considered premenopausal when they reported having 246 
had regular menses over the past twelve months. Women were considered 247 
perimenopausal if they reported having irregular menses over the past twelve months 248 
or if they indicated having had menses over the past 12 months, but were no longer 249 
menstruating at the time of enrollment.  250 
Menopausal age was defined as the self-reported age at the last menstrual period. 251 
Information on hysterectomy and oophorectomy status was also obtained through 252 
self-administered questionnaires. We considered women surgically postmenopausal 253 
if they had had a hysterectomy and/or uni- or bilateral oophorectomy before reaching 254 
natural menopause (Cooper and Thorp, 1999, Farquhar, et al., 2005, Hardy and Kuh, 255 
1999, Yasui, et al., 2012). Women with missing or incomplete questionnaire data on 256 
menstruation status were classified as premenopausal when they were younger than 257 
46 years, as perimenopausal when they were between 46 and 55 years of age, and 258 
as postmenopausal when they were older than 55 years at enrollment in which case 259 
they were excluded from the present analysis because of lack of information on age 260 
at menopause. 261 
 262 
Assessment of other covariates 263 
Information on smoking, alcohol consumption, physical activity and education level 264 
was based on self-report. Baseline questionnaires also included questions on 265 
reproductive factors such as age at first menstruation, number of live and stillbirths, 266 
and current and past use of OCs and hormone replacement therapy (HRT). Except 267 
for the Bilthoven cohort (The Netherlands), all centers collected information on the 268 
number of full-term pregnancies (the sum of live and stillbirths). In the Bilthoven 269 
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cohort, the number of children was used as a proxy for the number of full-term 270 
pregnancies. Women were also asked to give their age of starting and quitting 271 
smoking, and starting age and duration of OC use (in years). Information on the 272 
starting age of HRT use was collected slightly differently in each center. For this 273 
reason, start of HRT use was recoded in a uniform categorical variable (≤ 40 years, 274 
41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, ≥ 55 years) to maximize 275 
comparability across centers. 276 
In most centers, trained health professionals measured weight and height during a 277 
visit to the study center. Weight was corrected for the clothing worn during 278 
measurement in order to reduce heterogeneity due to protocol differences among 279 
centers and for self-reporting in Oxford participants using a prediction equation based 280 
on a comparison of self-reported and measured data (Haftenberger, et al., 2002). For 281 
the French cohort, we had to rely on self-report for 71% of the participants. BMI was 282 
calculated from the participant’s weight (kilograms) divided by the square of their 283 
height (square meters). 284 
 285 
Data analysis 286 
Missing values for covariates (all < 5%) were imputed using single imputation. Data 287 
were analyzed using a survival analysis approach, which allows for the inclusion of 288 
incomplete or censored observations in the estimation of ANM. Women who had had 289 
a hysterectomy and/or oophorectomy prior to menopause were censored at their age 290 
at surgery and pre- and perimenopausal women were censored at their age at 291 
enrollment. In all analyses, age from birth to menopause or censoring was used as 292 
the underlying time scale. We first used Kaplan-Meier analysis to estimate the 293 
median age at menopause for the entire cohort and after stratification for participant 294 
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characteristics. We then used Cox proportional hazards models to estimate the 295 
association between participant characteristics and ANM. Hazard ratios (HRs) 296 
derived from these models represent the risk of becoming naturally menopausal at a 297 
given age, with HRs less than 1 indicating a later menopause and HRs greater than 1 298 
indicating an earlier menopause compared to the reference. To account for the 299 
immortal person-time, which is the interval between birth and diabetes onset, 300 
representing a period of follow-up during which the outcome (menopause or 301 
censoring) cannot occur in exposed women (Rothman and Greenland, 1998, Shariff, 302 
et al., 2008, Sylvestre, et al., 2006, van Walraven, et al., 2004), diabetes status was 303 
modeled as a binary time-dependent variable, changing from unexposed at birth to 304 
exposed at the self-reported age at diagnosis. To investigate the impact of diabetes 305 
timing, we also entered age at diagnosis as a time-dependent categorical variable 306 
(age at diagnosis ≥ 50 years, 45-49 years, 40-44 years, 30-39 years, 20-29 years, 307 
10-20 years, < 10 years) into the model.  308 
Analyses were adjusted for potential confounders in three consecutive models and all 309 
models were stratified by center to account for study center effects (i.e. questionnaire 310 
design and covariate measurement). The first model was adjusted for age. Next, we 311 
added reproductive factors to the model: age at menarche (continuous), number of 312 
full-term pregnancies (0, 1, 2, ≥3) and OC and HRT use (yes/no). In the final 313 
multivariable model, we further adjusted the analyses for known diabetes risk factors 314 
including BMI (continuous), smoking (yes/no), alcohol consumption (< 10 g/day, 10-315 
24 g/day, 25-50 g/day and > 50 g/day), physical activity (inactive, moderately 316 
inactive, moderately active, active) and education level (none, primary school, 317 
technical or professional school, secondary school, longer education). Similar to 318 
diabetes status, premenopausal exposures to smoking and OCs were modeled as 319 
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binary time-dependent covariates with exposure starting at the self-reported age at 320 
smoking and OC initiation, and ending at cessation or censoring. HRT use before 321 
reaching natural menopause was modeled as a categorical variable (yes versus no).  322 
The proportional hazards assumption was assessed by visual inspection of the 323 
Schoenfeld residual plots, which did not indicate violation of the assumption. 324 
We also performed several sensitivity analyses. Hormone use prior to menopause 325 
may mask a woman’s true menopausal age. To investigate the impact of this 326 
potential misclassification, we performed a separate analysis in which we excluded 327 
women who used HRT prior to menopause and women who used OCs in the year 328 
before or after their menopause. Because the age at entry varied between 20 and 97 329 
years, a cohort effect may have confounded the association. To investigate this, we 330 
additionally adjusted the analyses for date of birth.  331 
Some EPIC centers validated the self-reported diagnosis of diabetes at baseline by 332 
cross-referencing with additional information sources [including: verification by a 333 
medical practitioner, use of diabetes medication, repeated self-report of diabetes 334 
diagnosis in follow-up questionnaires, linkage to diabetes registries, or a glycated 335 
hemoglobin (HbA1c) concentration of above 6% (42 mmol/mol; values based on 336 
registry information, Malmø only)]. To investigate the impact of potential 337 
misclassification due to self-reporting of diabetes, we also repeated the analyses in 338 
centers with verified diabetes cases only. All statistical analyses were performed 339 
using STATA, version 11.0 (Stata Corp., College Station, TX, USA). 340 
 341 
Results 342 
Participant characteristics of the study population are summarized in Table 1. The 343 
mean (SD) age was 50.6 (10.2) years and 131,923 (51.0%) women were still 344 
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menstruating. The estimated median ANM in the entire study population was 52.0 345 
years. The mean age at diabetes diagnosis was 47.3 years old (SD=13.2). Table 2 346 
shows the crude ANM across strata of participant characteristics and the 347 
corresponding HRs after multivariable adjustment. Current and former smoking and a 348 
low educational level were associated with an earlier onset of menopause, while late 349 
menarche, OC use and being parous were associated with a later menopause. 350 
Menopause was also delayed in women who were physically active and women who 351 
consumed alcoholic drinks.  352 
In total, 5,999 women had a self-reported diagnosis of diabetes of whom 2,752 had 353 
diabetes before menopause (defined as age at diagnosis < age at menopause or 354 
censoring). Table 3 shows the HRs for natural menopause according to diabetes 355 
status. Overall, diabetics did not have a statistically significant lower risk of becoming 356 
menopausal than non-diabetics (HR = 0.94; 95% CI 0.89-1.01). Analyses for age at 357 
diagnosis showed that women with diabetes before the age of 20 years were more 358 
likely to have an earlier menopause (10-20 years: HR = 1.43; 95% CI 1.02-2.01, < 10 359 
years: HR = 1.59; 95% CI 1.03-2.43), whereas women with diabetes at age 50 years 360 
and older were more likely to enter menopause at a later age (HR = 0.81; 95% CI 361 
0.70-0.95). None of the other categories of age at diagnosis were associated with 362 
ANM (Table 3, models 1-3).  363 
Results were not materially different when we excluded women who used HRT prior 364 
to menopause and/or OCs around the time of menopause, although the association 365 
with diabetes before the age of 10 years was slightly strengthened (Table 4). Results 366 
were also unchanged after adjusting the analyses for birthdate (Table 4). When 367 
restricting to verified diabetes cases, the associations yielded a similar HR for women 368 
with a late diabetes diagnosis, but the association with an early diabetes diagnosis 369 
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attenuated towards the null and was no longer statistically significant, although 370 
numbers were very small in these groups (Table 4).   371 
 372 
Discussion 373 
In the present study, we found no statistically significant overall association between 374 
diabetes and ANM. However, when looking at age of diagnosis, women with diabetes 375 
before the age of 20 years reached menopause earlier, whereas menopausal onset 376 
was delayed in women having diabetes after 50 years of age. For diabetes onset 377 
between the ages 20 and 50 years, no association with ANM was found. All 378 
associations remained similar after adjusting for age, smoking, reproductive factors 379 
and diabetes risk factors. 380 
There are several aspects that need to considered when interpreting our findings. 381 
The strengths of our study include its large sample size and the measurement of a 382 
broad set of potential confounders. Except for BMI and number of full-term 383 
pregnancies, covariate measurement was fully standardized across centers. Well-384 
known associations with smoking status, education and parity were replicated, which 385 
can be interpreted as an internal validation of our data.  386 
A potential source of bias that cannot be controlled for is survival bias. In our study, 387 
participants were required to have survived the time between exposure and study 388 
entry. Participants with diabetes are probably less likely to participate in a study, 389 
because of their illness and poorer survival (Barr, et al., 2007, Soedamah-Muthu, et 390 
al., 2006). Indeed, the prevalence of diabetes in our study sample was somewhat 391 
lower than expected (King, et al., 1998, Wild, et al., 2004). Since mortality has been 392 
associated with early menopause (Atsma, et al., 2006), an association between 393 
early-onset diabetes and younger ANM could have been biased toward the null. On 394 
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the other hand, the association between late-onset diabetes and older ANM might 395 
have been overestimated, although survival bias is probably less of a problem here, 396 
because the time between diabetes diagnosis and study entry is much smaller. 397 
Future prospective studies following women through menopause are needed to 398 
assess the impact of this potential bias.  399 
Second, we cannot be certain about the exact sequence of diabetes and menopause 400 
in women in whom both events occur approximately around the same age (i.e. 401 
reverse causation). Moreover, the menopause transition is a process that takes at 402 
least 3 years but this is highly variable and can be much longer (Harlow, et al., 2012) 403 
and diabetes occurs at least 4 to 7 years prior to diagnosis (Harris, et al., 2012). 404 
Thus, we cannot rule out the possibility that women with a short interval between 405 
menopause and diabetes were misclassified in our study. Third, assessment of both 406 
diabetes and menopause status was based on self-report, not verified by medical 407 
records. However, previous studies have shown that the validity and reproducibility of 408 
self-reported age at menopause is acceptable (Cairns, et al., 2011, Colditz, et al., 409 
1987, den Tonkelaar, 1997). Moreover, the replication of well-known associations 410 
with smoking status, education and parity suggests that recall of menopausal age 411 
was reasonably good. Although the probability of correct recall is lower when more 412 
time has passed (Colditz, et al., 1987, den Tonkelaar, 1997), it seems unlikely that 413 
recall of menopausal age is different for  diabetes cases compared to non-cases. In 414 
our data the percentage of women that had missing data on menopausal status was 415 
indeed similar in diabetes cases compared to non-cases. Moreover, the level of 416 
agreement between self-reported diagnosis of diabetes and diagnosis based on 417 
medical records was fairly good (75%) (Langenberg, et al., 2011, Sluik, et al., 2011). 418 
Results restricted to verified cases yielded comparable estimates, although due to 419 
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the small numbers associations were all non-significant and interpretation is difficult. 420 
Only self-reported cases were validated, and no information is available on medical 421 
diagnoses in those without a diabetes self-report. Therefore, false-negative cases 422 
may have been present. This may have led to an underestimation of the effect. 423 
However, as the prevalence of diabetes in our cohort is low (2.3%), and most of the 424 
cases will have been identified, the effect of fase-negative reports will have been 425 
small. Although the mean age at diagnosis was a bit later compared to the self-426 
reported mean age at diagnosis among the verified cases, it is unlikely that this will 427 
have impacted our findings, since the timing of diagnosis reporting is not likely to be 428 
influenced by menopausal status. 429 
Finally, we could not distinguish between the effects of T1D and T2D, as this 430 
information was not available in EPIC. The decreasing age at T2D onset is a 431 
relatively recent phenomenon (Chen, et al., 2012, Haines, et al., 2007). Since women 432 
of the EPIC cohort were recruited in the mid-1990s, it seems reasonable to assume 433 
that the younger ANM observed in women with diabetes before the age of 20 years is 434 
a T1D effect. In women with diabetes diagnosed between the age of 20 and 30 the 435 
type of diabetes could also be gestational diabetes, making it even more difficult to 436 
draw firm conclusions.  437 
Based on the literature, an accelerating effect of T1D on ANM might be plausible. 438 
Dorman et al (Dorman, et al., 2001) were the first to report an earlier onset of 439 
menopause in women with T1D, although the number of postmenopausal women 440 
was very small. In a more recent study among Finnish women with T1D, ANM was 441 
not associated with age at diabetes diagnosis, although patients with severe 442 
microvascular diabetes complications (proliferative retinopathy and nephropathy) 443 
were more likely to enter menopause early than those without (Sjoberg, et al., 2011). 444 
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However, compared to the general Finnish population, women with T1D had a 1.5 445 
years later median ANM (Sjoberg, et al., 2011). Furthermore, bBoth studies, 446 
however, were limited by small sample sizes and like ours were based on cross-447 
sectionally collected data. There is some biological evidence that T1D may have a 448 
direct deleterious effect on ovarian function. Oocyte maturation and ovarian follicular 449 
development are impaired in animal models of T1D (Chang, et al., 2005, Colton, et 450 
al., 2003) and in women with T1D an earlier decrease in AMH levels has been 451 
reported (Soto, et al., 2009), which is indicative of a smaller ovarian reserve. 452 
Diabetes diagnosed after the age of 45 years is most likely T2D. A delaying effect of 453 
T2D on ANM has not been reported before (Lopez-Lopez, et al., 1999), and is not in 454 
agreement with recent studies suggesting the opposite association (Aydin, 2010, Isik, 455 
et al., 2012).  456 
In conclusion, our results suggest that diabetes may influence ANM. Given the 457 
increasing prevalence of diabetes in women of childbearing age (Lawrence, et al., 458 
2008, Patterson, et al., 2009), future longitudinal studies with continued follow-up of 459 
premenopausal women are needed to replicate these findings and to explore the 460 
underlying mechanisms of the observed associations.  461 
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Table 1. Characteristics of the study population (N = 258,898) from the European 
Prospective Investigation into Cancer and Nutrition (EPIC), enrolled between 1992 and 2000. 
Age at entry (years), mean (SD) 50.6 (10.2) 
BMI (kg/m2), mean (SD) 25.2 (4.6) 
Menopausal status, % (N)  
  Pre- or perimenopausal 
  Natural postmenopausal 
  Surgical postmenopausal 
 
51.0 (131,923) 
34.4 (88,992) 
14.7 (37,983) 
Age at menarche (years), mean (SD)  * 13.0 (1.6) 
Number of full-term pregnancies, % (N) * 
  0  
  1 
  2 
  ≥ 3 
 
14.9 (38,575) 
15.9 (41,273) 
40.2 (104,128) 
26.0 (67,381) 
Ever OC use, % (N) * 58.4 (151,138) 
Ever HRT use, % (N) *  19.2 (49,799) 
Smoking status, % (N) * 
  Never 
  Former 
  Current 
 
58.5 (151,559) 
21.8 (56,556) 
18.0 (46,714) 
Alcohol consumption, % (N) * 
  < 10 g/day 
  10-24 g/day 
  25-50 g/day 
  > 50 g/day 
 
69.3 (179,485) 
20.8 (53,837) 
7.5 (19,334) 
1.5 (3,897) 
  2
Education, % (N) * 
  None 
  Primary school  
  Technical or professional school 
  Secondary school 
  Longer education 
 
5.8 (14,942) 
24.3 (62,982) 
19.6 (50,814) 
22.9 (59,356) 
23.7 (61,365) 
Physical activity, % (N) * 
  Inactive 
  Moderately inactive 
  Moderately active 
  Active 
 
24.6 (63,696) 
34.9 (90,439) 
23.7 (61,228) 
15.7 (40,596) 
Diabetes, % (N) 2.3 (5,999) 
Age at diabetes diagnosis, (years) mean 
(SD) 
47.3 (13.2) 
Values are expressed as mean (SD), unless stated otherwise. OC = oral 
contraceptives; HRT = hormone replacement therapy * variables with missing values 
(all < 5%) 
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Table 2. Associations of reproductive and lifestyle factors with age at natural 
menopause. 
Participant characteristic Median ANM 
(IQR) a  
Adjusted HR (95% 
CI) *,b 
Age at menarche 
  < 12 years 
  ≥ 12 years 
 
52 (49-54) 
52 (50-54) 
 
REF (1.00) 
0.95 (0.93-0.96) 
Number of full-term pregnancies 
  0 
  1 
  2 
  ≥ 3 
 
51 (49-54) 
52 (49-54) 
52 (50-55) 
52 (49-54) 
 
REF (1.00) 
0.89 (0.87-0.92) 
0.86 (0.84-0.88) 
0.85 (0.83-0.87) 
Ever use of oral contraceptives 
  Never 
  Ever 
 
51 (49-54) 
52 (50-55) 
 
REF (1.00) 
0.93 (0.92-0.95) 
BMI 
  < 25 kg/m2 
  25-30 kg/m2 
  ≥ 30 kg/m2 
 
52 (50-55) 
52 (49-54) 
52 (49-54) 
 
REF (1.00) 
1.02 (1.01-1.04) 
1.01 (0.99-1.03) 
Smoking status 
  Never 
  Former 
  Current 
 
52 (50-54) 
52 (50-55) 
51 (49-54) 
 
REF (1.00) 
1.05 (1.03-1.07) 
1.35 (1.32-1.37) 
Alcohol consumption 
  < 10 g/day 
 
52 (49-54) 
 
REF (1.00) 
  4
  10-25 g/day 
  25-50 g/day 
  > 50 g/day 
52 (50-55) 
52 (50-55) 
52 (50-55) 
0.94 (0.93-0.96) 
0.91 (0.89-0.93) 
0.91 (0.86-0.97) 
Physical activity 
  Inactive 
  Moderately inactive 
  Moderately active 
  Active 
 
51 (49-54) 
52 (50-54) 
52 (50-55) 
52 (50-55) 
 
REF (1.00) 
0.96 (0.94-0.97) 
0.92 (0.91-0.94) 
0.96 (0.94-0.98) 
Education 
  None 
  Primary school 
  Technical or professional school
  Secondary school 
  Longer education  
 
50 (48-53) 
51 (49-54) 
52 (49-54) 
52 (50-55) 
52 (50-55) 
 
1.54 (1.49-1.58) 
1.31 (1.28-1.34) 
1.18 (1.15-1.20) 
1.04 (1.01-1.06) 
REF (1.00) 
 
ANM: age at natural menopause, IQR: interquartile range, CI: confidence interval 
REF: reference  
*The hazard ratios (HRs) represent the risk of becoming naturally menopausal at a 
given age, with HRs less than 1 indicating a later menopause and HRs greater than 1 
indicating an earlier menopause compared to the reference 
a Median ANM was estimated using Kaplan Meier analyses. 
b HRs derived from multivariable adjusted Cox proportional hazards models including 
reproductive factors (age at menarche, number of full-term pregnancies, ever use of 
OCs and HRT) and diabetes risk factors (BMI, smoking status, alcohol consumption, 
physical activity and education) 
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Table 3. Hazard ratios of natural menopause according to diabetes status and age at 
diagnosis.  
 HR (95% CI) * 
 Model 1 
(N = 258,898) 
Model 2 
(N = 258,898) 
Model 3 
(N = 258,898) 
Diabetes before 
menopause 
   
No (N = 256,146) REF (1.00) REF (1.00) REF (1.00) 
Yes  (N = 2,752) 0.97 (0.91-1.03) 0.95 (0.89 -1.01) 0.94 (0.89-1.01) 
    
Age at diabetes 
diagnosis (years) 
   
No diabetes before 
menopause  
REF (1.00) REF (1.00) REF (1.00) 
≥ 50 (N = 317) 0.85 (0.73-0.99) 0.82 (0.70-0.96) 0.81 (0.70-0.95) 
45-49 (N = 649) 0.91 (0.81-1.02) 0.90 (0.81-1.01) 0.91 (0.81-1.02) 
40-44 (N = 444) 1.02 (0.87-1.19) 1.01 (0.86-1.18) 1.00 (0.86-1.17) 
30-39 (N = 715) 1.00 (0.87-1.14) 0.98 (0.85-1.12) 0.96 (0.84-1.10) 
20-29 (N = 394) 1.07 (0.89-1.30) 1.03 (0.85-1.24) 0.99 (0.82-1.20) 
10-20 (N = 161) 1.20 (0.85-1.69) 1.42 (1.01-1.99) 1.43 (1.02-2.01) 
< 10 (N = 72) 1.56 (1.01-2.39) 1.66 (1.08-2.55) 1.59 (1.03-2.43) 
Cox proportional hazards models stratified by center and including diabetes status 
and age at diabetes diagnosis as time-dependent variables. 
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*HRs represent the risk of becoming naturally menopausal at a given age, with HRs 
less than 1 indicating a later menopause and HRs greater than 1 indicating an earlier 
menopause compared to the reference. 
Model 1: adjusted for age 
Model 2: Model 1 plus reproductive factors (age at menarche, number of full-term 
pregnancies, OC use and HRT) 
Model 3: Model 2 plus diabetes risk factors (BMI, smoking, alcohol consumption, 
education and physical activity) 
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Table 4. Hazard ratios of natural menopause according to diabetes status and age at diagnosis - sensitivity analyses. 
 HR (95% CI) *    
 Model 3 
(N = 258 898) 
Model 4 
(N = 234 240) 
Model 5 
(N = 258 898) 
Model 6  
(N = 119 613) 
Diabetes before menopause     
No (N = 256 146) REF (1.00) REF (1.00) REF (1.00) REF (1.00)  
(N = 118 782) 
Yes  (N = 2752) 0.94 (0.89-1.01) 0.93 (0.87-1.00) 0.95 (0.89-1.01) 0.88 (0.79-0,98)  
(N = 831) 
     
Age (years) at diabetes diagnosis     
No diabetes before menopause  REF (1.00) REF (1.00) REF (1.00) REF (1.00) 
≥ 50 (N = 317) 0.81 (0.70-0.95) 0.83 (0.71-0.98) 0.81 (0.70-0.95) 0.80 (0.62-0.95)  
(N = 171) 
45-49 (N = 649) 0.91 (0.81-1.02) 0.88 (0.77-1.00) 0.91 (0.81-1.02) 0.80 (0.65-0.97) (N = 221)  
40-44 (N = 444) 1.00 (0.86-1.17) 1.01 (0.85-1.19) 1.00 (0.86-1.17) 0.92 (0.72-1.18) (N = 164) 
  8 
30-39 (N = 715) 0.96 (0.84-1.10) 0.92 (0.80-1.07) 0.97 (0.84-1.11) 1.12 (0.87-1.44) (N = 183) 
20-29 (N = 394) 0.99 (0.82-1.20) 1.00 (0.82-1.22) 1.00 (0.82-1.20) 1.14 (0.79-1.65) (N = 69) 
10-20 (N = 161) 1.43 (1.02-2.01) 1.41 (0.92-2.16) 1.44 (1.02-2.03) 1.02 (0.14-7.24) (N = 17) 
< 10 (N = 72) 1.59 (1.03-2.43) 1.79 (1.13-2.84) 1.59 (1.03-2.43) No fit possible   (N = 6)  
Cox proportional hazards models stratified by center and including diabetes status and age at diabetes diagnosis as time-dependent variables. 
*) HRs represent the risk of becoming naturally menopausal at a given age, with HRs less than 1 indicating a later menopause and HRs greater than 1 
indicating an earlier menopause compared to the reference. 
Model 3: adjusted for age, reproductive factors (age at menarche, number of full-term pregnancies, OC use and HRT) and diabetes risk factors (BMI, 
smoking, alcohol consumption, education and physical activity) 
Model 4: Model 3 after excluding women using HRT prior to menopause and/or women using OCs around menopause 
Model 5: Model 3 plus date of birth 
Model 6: Model 3  restricted to verified diabetes cases only (in a subset of EPIC: 13 centers in 5 countries (Italy: Florence, Milan, Naples, Ragusa, Turin; 
Spain: Pamplona, San Sebastian; Netherlands: Bilthoven, Utrecht; Germany: Heidelberg, Potsdam; Denmark; Aarhus, Copenhagen)  
 
 
